GreatPoint Ventures

Type

Venture Capital

Status

Active

Location

San Francisco, United States

Total investments

110

Average round size

31M

Portfolio companies

71

Rounds per year

12.22

Lead investments

17

Follow on index

0.35

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareAnalyticsArtificial IntelligenceFood and BeverageMachine LearningHealth CareSaaSMedical DeviceHealth Insurance

Summary

GreatPoint Ventures appeared to be the VC, which was created in 2015.

The higher amount of exits for fund were in 2019. The average startup value when the investment from GreatPoint Ventures is more than 1 billion dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2019. Speaking about the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this GreatPoint Ventures performs on 23 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year.

The fund was created by Andrew Perlman, Ray Lane. The overall number of key employees were 5.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the GreatPoint Ventures, startups are often financed by Khosla Ventures, Globespan Capital Partners, Tim Disney. The meaningful sponsors for the fund in investment in the same round are Tao Capital Partners, Khosla Ventures, DNS Capital. In the next rounds fund is usually obtained by Khosla Ventures, Third Rock Ventures, Globespan Capital Partners.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Machine Learning, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Uptake, Beyond Meat, Even Financial. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Show more

Investor highlights

Industry focus
B2B/EnterpriseHealthcareBiotech/Life SciencesFoodtech
Stage focus
Seed
Check size
250K — 20M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
110
Lead investments
17
Exits
3
Rounds per year
12.22
Follow on index
0.35
Investments by industry
  • Health Care (37)
  • Software (35)
  • Machine Learning (16)
  • Artificial Intelligence (16)
  • Analytics (16)
  • Show 102 more
Investments by region
  • United States (100)
  • China (1)
  • Israel (3)
  • Malaysia (1)
  • Canada (1)
  • Show 1 more
Peak activity year
2021
Number of Unicorns
5
Number of Decacorns
6
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
318M
Group Appearance index
0.93
Avg. company exit year
12
Avg. multiplicator
12.22
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Abett 21 May 2024 Information Technology, Health Care Early Stage Venture 11M United States, Washington, Seattle
Nixtla 24 Apr 2023 Software, Machine Learning Seed 4M United States, Pennsylvania, Pittsburgh

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.